Quote this publication Share Print

DIACOMIT

-
Opinions on drugs - Posted on Aug 01 2008

Reason for request

Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals

-


Actual benefit

Important

The actual benefit of DIACOMIT is substantial.


Improvement in actual benefit

III (modéré)

DIACOMIT provides a moderate (level III) improvement in actual benefit in the management of patients with severe myoclonic epilepsy in infancy when the sodium valproate-clobazam combination does not provide adequate control.


Contact Us

Évaluation des médicaments
All our publication